Page 2 - Lars Wilde News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The filing shows that ATAI has raised an aggregate of $362.3 million from private investors so far. It is planning to sell its shares on New York's tech-focused Nasdaq market under the symbol ATAI. A date for the IPO has not been set. Underwriters for the IPO include Credit Suisse, Citigroup, Cowen, and Berenberg. ATAI, which describes itself as a drug development platform, was set up to acquire, incubate and develop psychedelics and other drugs that can be used to treat depression, anxiety, addiction and other mental health conditions. The company, which has roughly 50 staff in offices acros...

Quercis Announces Executive Leadership Appointments Proven life science entrepreneurs from COMPASS Pathways appointed to key operational roles News provided by Share this article Share this article ZUG, Switzerland, April 13, 2021 /PRNewswire/ -- Quercis Pharma AG, a private, clinical stage biopharmaceutical company leveraging its novel antithrombotic platform, today announces the appointment of several new executives to the Company's leadership team.  John Boghossian, former Vice President of Operations at COMPASS Pathways, will join Quercis as Chief Executive Officer; Manon Veraart, forme...

COMPASS Pathways plc to participate in 20th Annual Needham Virtual Healthcare Conference COMPASS Pathways plc a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that George Goldsmith, Chairman, CEO and Co‑founder, and Lars Wilde, President, Chief Business Officer, and Co‑founder, will present a corporate update at 8:00am ET on 15 April at the 20 th Annual Needham Virtual Healthcare Conference. Members of the COMPASS … COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerati...

ATAI, which describes itself as a drug development platform, was set up to acquire, incubate and develop psychedelics and other drugs that can be used to treat depression, anxiety, addiction and other mental health conditions. The Berlin-headquartered company — founded in 2018 by entrepreneurs Christian Angermayer, Florian Brand, Lars Wilde and Srinivas Rao — announced its majority stake in Psyber on Wednesday. It declined to specify what it offered Psyber in exchange for the majority stake. In theory, a brain computer interface allows direct communication between a human brain and an ex...

COMPASS Pathfinder Ltd.: COMPASS Pathways plc to participate in 20th Annual Needham Virtual Healthcare Conference London, UK, April 09, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that George Goldsmith, Chairman, CEO and Co-founder, and Lars Wilde, President, Chief Business Officer, and Co-founder, will present a corporate update at 8:00am ET on 15 April at the 20 th Annual Needham Virtual Healthcare Conference. Members of the COMPASS managemen...